- BCIDP stands for Board Certified Infectious Diseases Pharmacist, credentialed by the Board of Pharmacy Specialties (BPS).
- The exam is 150 items (125 scored, 25 unscored) over 3 hours 45 minutes, scored on a 200-800 scale with 500 to pass.
- Therapeutics and Patient Management alone carries 60% of the exam - more than the other two domains combined.
- Initial certification costs $600; eligible retakes are $300, per the current Candidate's Guide.
The Acronym, Letter by Letter
BCIDP stands for Board Certified Infectious Diseases Pharmacist. Each word describes a specific piece of what the credential represents:
- Board Certified - the designation is awarded by a recognized pharmacy specialty board, not a private company or continuing-education vendor.
- Infectious Diseases - the specialty scope: antimicrobial therapeutics, resistant organisms, stewardship, and management of complex infections across patient populations.
- Pharmacist - the credential is held by a licensed pharmacist, not a physician, nurse, or technician.
If you've landed here because you saw "BCIDP" somewhere else and the details didn't match what you expected, that's addressed below. For a broader orientation to the credential itself, see What Is BCIDP? and BCIDP Meaning.
Who Issues the Credential
The Board Certified Infectious Diseases Pharmacist credential is issued by the Board of Pharmacy Specialties (BPS), the organization responsible for recognizing pharmacy specialty practice areas and administering their certification exams. Exams are delivered through Pearson VUE testing centers under a continuous-testing model, meaning candidates aren't limited to one or two fixed windows a year - instead, an approved candidate receives a 90-day authorization period during which they schedule and sit for the exam at a convenient time.
Why "BCIDP" Can Be Confusing
The letters "BCIDP" are sometimes used loosely online or applied to unrelated programs, which can lead to mismatched information - wrong fees, wrong exam length, wrong governing body. On this site, and specifically in this article, BCIDP refers exclusively to the Board Certified Infectious Diseases Pharmacist credential administered by BPS. If a source cites a different certifying organization, a different fee structure, or a different exam blueprint for "BCIDP," it is not describing this pharmacy specialty certification. When researching, always confirm the source ties back to BPS's own published Candidate's Guide and examination specifications.
Who Can Even Sit for the Exam
Before diving into exam mechanics, it's worth understanding who qualifies. BPS requires candidates to hold a recognized pharmacy degree, maintain an active pharmacist license or registration, and complete qualifying infectious diseases experience within seven years before applying. There are three accepted pathways:
- Four years of infectious diseases pharmacy practice experience
- An eligible PGY1 residency plus two years of infectious diseases practice
- An eligible PGY2 residency specifically in infectious diseases
Practice-based pathways require at least 50% of the candidate's work to fall within the infectious diseases specialty scope, along with post-licensure experience and an employer attestation confirming that scope. Every eligibility requirement must be fully completed before the application is submitted - there's no provisional or in-progress status accepted. Notably, a stewardship-course completion certificate is not a listed prerequisite, even though antimicrobial stewardship shows up heavily inside the exam content itself.
For a full breakdown of pathway documentation and attestation logistics, see BCIDP Requirements 2026: Eligibility, Prerequisites & How to Qualify.
What the Exam Actually Looks Like
The initial certification exam consists of 150 items - 125 scored questions and 25 unscored pretest items mixed in without identification - delivered over 3 hours 45 minutes. It's computer-based and administered at Pearson VUE testing centers. Most questions are traditional four-option multiple choice, though BPS notes that multiple-response and image-supported items can appear in some specialty exams.
Testing Conditions to Know
The exam environment has specific rules that affect pacing strategy.
- Closed-book with an on-screen scientific calculator only
- Answers are forward-only - no skipping ahead and returning to revisit questions
- No penalty for guessing, so every item should be answered
- No normal-laboratory-value table or unit-conversion chart is provided, so those values must be memorized
- One optional ten-minute unscheduled break is allowed, but it counts against your total exam time
Scoring is reported on a 200-800 scale**, with a passing score of **500 - it is not a raw percentage of questions answered correctly. Preliminary pass/fail status is available immediately after finishing under continuous testing, while official score reports follow within 45 days. For the exact scaled-score mechanics and what "500" really means statistically, see BCIDP Passing Score 2026: Exactly What You Need to Pass.
Remote testing exists only as a limited, case-by-case approval - most candidates should plan on an in-person Pearson VUE appointment. If you're weighing how demanding this format is compared to other pharmacy specialty exams, How Hard Is the BCIDP Exam? Complete Difficulty Guide 2026 walks through that comparison in more depth.
The Three Content Domains
The current examination specifications took effect October 1, 2025, based on an October 2024 content outline, and they define three domains with very uneven weighting. This weighting should directly shape how you allocate study time.
Domain 1: Pathophysiology and Epidemiology of Infections (18%)
Covers disease mechanisms, host-pathogen interactions, transmission patterns, and epidemiologic principles behind infectious processes.
- Organism-specific pathophysiology
- Epidemiologic trends and outbreak patterns
- Host immune response fundamentals
Domain 2: Therapeutics and Patient Management (60%)
By far the largest domain - nearly two-thirds of the exam. This is where antimicrobial selection, dosing, monitoring, and complex case management live.
- Empiric and directed antimicrobial therapy decisions
- Management across special populations (renal impairment, pregnancy, immunocompromised patients)
- Adverse effect recognition and therapy adjustment
Domain 3: Professional Practice (22%)
Includes antimicrobial stewardship specifically, which makes up 14% of the total exam on its own - nearly as much as the entire first domain.
- Antimicrobial stewardship program design and metrics
- Infection prevention collaboration
- Guideline development and quality improvement roles
Key Takeaway
Because Therapeutics and Patient Management is worth 60% of the exam, it deserves roughly three times the study time you give either other domain - and stewardship within Professional Practice deserves dedicated attention given its 14% standalone weight.
For anchor tables, item-writer emphasis, and sample question phrasing tied to each domain, see BCIDP Exam Domains 2026: Complete Guide to All 3 Content Areas.
Fees and Registration Mechanics
BPS uses a flat, standard fee structure for BCIDP rather than member/non-member pricing tiers. Initial certification costs $600. If a candidate does not pass and is eligible to retake, the retake fee is $300 under the current Candidate's Guide. The 2026 Candidate's Guide was updated August 26, 2026, so candidates should always confirm they're reading the current version before submitting an application.
| Item | Fee |
|---|---|
| Initial certification exam | $600 |
| Eligible retake exam | $300 |
| Annual maintenance (years 1-6 of cycle) | $125/year |
| Recertification (year 7 of cycle) | $400 |
For scheduling windows, application deadlines, and how the 90-day Pearson VUE authorization period actually plays out, see BCIDP Exam Dates 2026: Testing Windows, Deadlines & Scheduling. A full cost breakdown including recertification math over a full cycle is in BCIDP Certification Cost 2026: Complete Pricing Breakdown.
Staying Certified After You Pass
Passing the exam isn't the end of the obligation - BCIDP operates on a seven-year recertification cycle. Pharmacists pay $125 annually in years one through six for maintenance, then $400 in year seven for recertification, all while keeping an active pharmacist license.
For cycles beginning January 2024 onward, maintaining certification requires 100 development units, with at least 80 coming from BPS-approved assessed CPE units and up to 20 from CPD units (assessed CPE can substitute for CPD entirely if preferred). Alternatively, a pharmacist can choose to sit for the recertification examination instead, provided they also complete 20 CPD/CPE units. Either route requires at least two units and an Annual Reflection and Plan each year; the examination pathway specifically requires the 20 units and seven annual plans to be completed before applying to test. Cycles that started earlier retain their legacy pathway of either 100 approved CPE hours or the recertification exam.
Approved assessed-CPE providers include ASHP, ACCP, and the Society of Infectious Diseases Pharmacists (SIDP) - organizations closely tied to the infectious diseases pharmacy specialty itself, which is a useful signal of where ongoing professional development in this field tends to concentrate.
Who Actually Hires a BCIDP
Because the credential validates deep expertise in antimicrobial therapeutics and stewardship, employers seeking a Board Certified Infectious Diseases Pharmacist tend to include hospital systems building or expanding antimicrobial stewardship programs, academic medical centers with infectious diseases consult services, and health systems responding to regulatory or accreditation requirements around antimicrobial oversight. The Professional Practice domain's heavy stewardship weighting (14% of the total exam) reflects how central that function has become in real-world infectious diseases pharmacy roles. If you're evaluating career paths and compensation expectations tied to the credential, BCIDP Jobs and BCIDP Salary Guide 2026: Complete Earnings Analysis go into more detail, and Is the BCIDP Certification Worth It? Complete ROI Analysis 2026 weighs the investment against career outcomes.
A Domain-Weighted Way to Prepare
Generic study techniques matter less here than sequencing your study time to match domain weight. A structure like this respects the 60/22/18 split rather than treating all three domains equally:
Pathophysiology and Epidemiology of Infections (18%)
- Build organism and mechanism foundations early since Therapeutics content builds on this base
- Use active recall on transmission and epidemiologic patterns
Therapeutics and Patient Management (60%)
- Dedicate the largest block of calendar time here, proportional to its exam weight
- Work through case-based practice covering special populations and empiric therapy decisions
Professional Practice (22%), with stewardship emphasis
- Prioritize antimicrobial stewardship program mechanics given its 14% standalone weight
- Review infection prevention and guideline-development concepts
Full-length review and timed practice
- Simulate the forward-only, no-skip answer format under a 3 hour 45 minute clock
- Drill lab values and unit conversions since no reference chart is provided on exam day
For a complete week-by-week study plan built specifically around this domain structure, see BCIDP Study Guide 2026: How to Pass on Your First Attempt. And when you're ready to test your readiness under realistic timed conditions, practice exams on the main site mirror the forward-only, closed-book format you'll face on exam day.
Frequently Asked Questions
BCIDP stands for Board Certified Infectious Diseases Pharmacist, a credential issued by the Board of Pharmacy Specialties (BPS) to licensed pharmacists who meet eligibility requirements and pass the certification exam.
No. On this site, BCIDP refers exclusively to the Board Certified Infectious Diseases Pharmacist credential from BPS. Other programs may use similar-looking abbreviations, but they have different certifying bodies, fees, and exam formats and are not the same credential.
The exam has 150 total items - 125 scored and 25 unscored pretest questions - administered over 3 hours 45 minutes at a Pearson VUE testing center.
Therapeutics and Patient Management, which carries 60% of the exam - significantly more than Professional Practice (22%) or Pathophysiology and Epidemiology of Infections (18%).
Initial certification costs $600, and an eligible retake costs $300 under the current Candidate's Guide. After certification, maintenance runs $125 annually in years 1-6 and $400 in year 7 of the seven-year recertification cycle.